Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
American Journal of Infectious Diseases|March 6, 2010
Mortality among HIV-Infected Patients in Resource Limited Settings: A Case Controlled Analysis of Inpatients at a Community Care CenterNirmala Rajagopalan, Joyce B Suchitra, Anita Shet, et al.
Frontiers in Genome Editing|October 29, 2021
Off-Target Analysis in Gene Editing and Applications for Clinical Translation of CRISPR/Cas9 in HIV-1 TherapyAndrew Atkins, Cheng-Han Chung, Alexander G Allen, et al.
Frontiers in Genome Editing|May 1, 2023
Assessment of anti-HIV-1 guide RNA efficacy in cells containing the viral target sequence, corresponding gRNA, and CRISPR/Cas9Alexander G Allen, Cheng-Han Chung, Stephen D Worrell, et al.
Journal of Neurovirology|June 10, 2024
CD4 nadir and neurocognitive trajectories in people living with HIVRazmig Garabet, Will Dampier, Shinika Tillman, et al.
American Journal of Infectious Diseases|March 31, 2010
Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A ReviewBryan P Irish, Zafar K Khan, Pooja Jain, et al.
Molecular Therapy. Nucleic Acids|August 21, 2020
Safe CRISPR-Cas9 Inhibition of HIV-1 with High Specificity and Broad-Spectrum Activity by Targeting LTR NF-κB Binding SitesCheng-Han Chung, Alexander G Allen, Andrew J Atkins, et al.
MOJ Immunology|August 1, 2015
Modeling Bone Marrow Progenitor Cell Differentiation and Susceptibility to HIV-1 InfectionAikaterini Alexaki, Shane J Quiterio, Michael R Nonnemacher, et al.
International Journal of Molecular Sciences|June 14, 2016
Prolonged Morphine Exposure Induces Increased Firm Adhesion in an in Vitro Model of the Blood-Brain BarrierMarianne Strazza, Vanessa Pirrone, Brian Wigdahl, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 16, 2014
Cocaine alters cytokine profiles in HIV-1-infected African American individuals in the DrexelMed HIV/AIDS genetic analysis cohortNirzari Parikh, Will Dampier, Rui Feng, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 26, 2010
Structural and functional studies of CCAAT/enhancer binding sites within the human immunodeficiency virus type 1 subtype C LTRYujie Liu, Michael R Nonnemacher, Devin L Stauff, et al.
Pageof 9